Evaluation of Bilirubin Estimates in Newborns From Smartphone Digital Images in a Population in Botswana
NCT06399146 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2024-05-03
Summary
This project aims to test a novel smartphone application, Picterus, which provides a cheaper, patient-friendly, and more readily means of neonatal jaundice detection. For this purpose, the study aims to collect data from newborns with a broad range of bilirubin levels and high melanin content in a population in Botswana.
Conditions
- Neonatal Jaundice
- Neonatal Hyperbilirubinemia
Interventions
- DEVICE
-
Picterus App
Take a photo off the patient's skin (sternum).
Sponsors & Collaborators
-
Picterus AS
collaborator INDUSTRY -
Hillerod Hospital, Denmark
lead OTHER
Principal Investigators
-
Bo M Hansen, prof · Hillerod Hospital, Denmark
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 24 Hours
- Max Age
- 14 Days
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-03-01
- Primary Completion
- 2024-09-01
- Completion
- 2024-10-01
Countries
- Botswana
Study Locations
More Related Trials
-
Evaluation of Bili-ruler, a Low-cost, Plastic Icterometer for Community-based Screening of Jaundice in Newborns
NCT06687746 ·Status: ACTIVE_NOT_RECRUITING
-
Transcutaneous Bilirubin Measurements in Neonates Post Phototherapy
NCT04719104 ·Status: UNKNOWN ·Phase: NA
-
Home Based Phototherapy for Neonatal Jaundice
NCT03933423 ·Status: UNKNOWN ·Phase: NA
-
Serum Erythropoietin Level in Perinatal Asphyxia
NCT05018364 ·Status: COMPLETED
-
Transcutaneous Bilirubinometry in Neonates With the BiliCare System Compared to the Invasive TSB Test
NCT02372071 ·Status: COMPLETED ·Phase: NA
-
Reverse Phototherapy With Super Light-emitting Diode(Super-LED) for Hyperbilirubinemia in Term and Late Preterm Infants
NCT01340339 ·Status: UNKNOWN ·Phase: PHASE4
-
Dry Blood Spot Screening Test for Neonatal Cholestasis Patients
NCT03667534 ·Status: UNKNOWN
-
BUBOLight®, a New Phototherapy Device for the Treatment of the Newborn's Jaundice
NCT04365998 ·Status: RECRUITING ·Phase: NA
-
Implementation of a Clinical Decision Rule for Treatment of Neonatal Jaundice in the Emergency Department
NCT02446951 ·Status: COMPLETED
-
Fluid in Neonatal Hyperbilirubinemia
NCT03684499 ·Status: UNKNOWN ·Phase: NA
-
Broad Band Emission LED Phototherapy Source Versus Narrow Band
NCT05257369 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Yinzhihuang Oral Liquid on Indirect Bilirubin of Neonates With Glucose-6-phosphate Dehydrogenase Deficiency
NCT02594904 ·Status: UNKNOWN ·Phase: PHASE4
-
Development of a Neonatal Jaundice Treatment Accelerator by Redirection of Unused Light During Phototherapy
NCT04021927 ·Status: WITHDRAWN ·Phase: NA
-
Accuracy of TcB Measurements During and After Phototherapy
NCT07080398 ·Status: COMPLETED
-
Comparison of Double Pad Fiber Optic Device Versus Conventional Phototherapy
NCT04585828 ·Status: UNKNOWN ·Phase: NA
-
Use of a New Phototherapy Device (BBloo®) for the Treatment of Hyperbilirubinemia in the Newborn Infant
NCT02156050 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical and Developmental Outcomes of Babies Who Became Yellow in the First Month of Life
NCT02927093 ·Status: COMPLETED
-
Bedside Optical Retinal Assessment of Hypoxic Ischemic Encephalopathy in Infants
NCT03640494 ·Status: COMPLETED
-
Filtered Sunlight Phototherapy to Treat Significant Jaundice: Safety and Efficacy in Neonates
NCT02612727 ·Status: COMPLETED ·Phase: NA
-
Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns
NCT03599258 ·Status: COMPLETED ·Phase: NA
-
Light-emitting Diodes (LED) Phototherapy for Hyperbilirubinemia of Term Newborn
NCT01136577 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Erythropoietin to Improve Survival and Neurological Outcome in Hypoxic Ischemic Encephalopathy
NCT01732146 ·Status: COMPLETED ·Phase: PHASE3
-
Bilirubin Neurotoxicity (BN) and Neurodevelopmental Impairment (NDI) in Extremely Preterm (EP) Infants: Avoidable by Reducing the Usual Intravenous Lipid (UL) Administration
NCT04584983 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hyperbilirubinemia and Retinopathy of Prematurity in Preterm Infants: a Retrospective Study.
NCT05806684 ·Status: UNKNOWN
-
New Phototherapy Device to Treat Patients With Crigler-Najjar Disease
NCT02356978 ·Status: UNKNOWN ·Phase: NA